REGULUS THERAPEUTICS INC's ticker is RGLS and the CUSIP is 75915K200. A total of 41 filers reported holding REGULUS THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $8,000 | +300.0% | 28,441 | +315.7% | 0.00% | – |
| Q4 2021 | $2,000 | -97.3% | 6,841 | -92.6% | 0.00% | -100.0% |
| Q2 2021 | $75,000 | +7.1% | 91,872 | +105.0% | 0.00% | +100.0% |
| Q1 2021 | $70,000 | -57.1% | 44,806 | -63.0% | 0.00% | -80.0% |
| Q4 2020 | $163,000 | +1064.3% | 120,986 | +353.0% | 0.01% | – |
| Q3 2020 | $14,000 | -53.3% | 26,707 | -39.6% | 0.00% | -100.0% |
| Q2 2020 | $30,000 | – | 44,186 | +21993.0% | 0.00% | – |
| Q2 2019 | $0 | -100.0% | 200 | -82.6% | 0.00% | – |
| Q1 2019 | $1,000 | -75.0% | 1,149 | -73.5% | 0.00% | – |
| Q4 2018 | $4,000 | – | 4,338 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| DAFNA Capital Management LLC | 5,555,555 | $1,656,000 | 0.43% |
| NEA Management Company, LLC | 14,451,147 | $4,306,000 | 0.12% |
| Sarissa Capital Management LP | 1,851,851 | $552,000 | 0.05% |
| Ikarian Capital, LLC | 1,289,130 | $384,000 | 0.05% |
| FEDERATED HERMES, INC. | 29,048,265 | $8,656,000 | 0.02% |
| WealthTrust Axiom LLC | 68,000 | $20,000 | 0.01% |
| All Terrain Financial Advisors, LLC | 15,000 | $4,000 | 0.00% |
| GYL FINANCIAL SYNERGIES, LLC | 34,000 | $10,000 | 0.00% |
| BOOTHBAY FUND MANAGEMENT, LLC | 124,056 | $37,000 | 0.00% |
| McGuire Investment Group, LLC | 15,000 | $4,000 | 0.00% |